This four-part series marks 4G Clinical’s milestone of 1,000 studies launched. Through a series of conversations, we look back at what it took to get here — from the lessons we’ve learned to the trust we’ve built with our clients. Across the episodes, leaders from Product, Engineering, Sales, and Delivery share unique perspectives on innovation, collaboration, and the people and partnerships behind this achievement. Together, we celebrate the journey, reflect on the past, and look ahead to the future of clinical trial technology.
About the Episode
In the final episode of 4G Clinical’s milestone series, hosts Libbi Rickenbacher and Kathleen Greenough step back to examine the themes that surfaced across conversations with product, sales, and delivery leaders. Together, they explore what these perspectives reveal about how 4G has grown, what it has learned, and how the organisation has evolved to support more than a thousand studies worldwide.
Their discussion highlights the practical lessons behind that growth, including the shift from early flexibility to scalable best practices, the importance of shared standards, and the role of cross-functional alignment in keeping studies running smoothly across regions. Libbi and Kathleen reflect on how trust, operational clarity, and a consistent approach to study design and delivery have strengthened 4G’s ability to meet increasingly complex sponsor needs.
For listeners, the episode offers a grounded view of what sustainable scale actually requires in RTSM and why these principles matter for sponsors, partners, and patients. It provides a set of transferable insights into how organisations can evolve without losing their core strengths.
Rather than looking back nostalgically, this episode distils the insights that matter most for the next phase of growth and innovation. It offers a clear, thoughtful perspective on what it really takes to deliver RTSM at scale and what these lessons signal for the future of clinical trials.
VP, Marketing and Partnerships
Libbi Rickenbacher, Sr. Director of Product Strategy and Partnerships, has over 15 years of experience in the field of life sciences and is an e-clinical RTSM solutions subject matter expert. Her experience lies in building and managing accounts, clients, and strategic initiatives. She holds a BA in both Neuroscience and Psychology and a Doctorate (PhD) in Neuroscience.
VP, Biotech Operations
Kathleen Greenough, Vice President of Biotech Customer Operations at 4G Clinical, has 16 years of experience in life sciences spanning Clinical Operations, Finance, and IT. Her wide range of solutions implementation expertise includes RTSM, CTMS, trial costing tools, OLAP financial suites and patient enrollment planning. Kathleen has also spent many years as a Clinical Financial Planner and Analyst at a major biotech in Cambridge, MA, gaining a broad and deep understanding of the challenges inherent in Clinical Development. Specializing in software adoption and a frequent speaker at industry conferences, Kathleen is most in her element when working within a user community to facilitate solutions that are insightful and truly helpful.